Stewart Perry

I primarily act for insolvency practitioners, various categories of financier, distressed companies and their directors. My experience covers the full range of insolvency work, from purchases and sales in trading insolvencies to multinational multimillion pound frauds. By way of example, I acted for:

• the administrators of Redx Pharma Plc, an AIM listed pharma company, in a ground-breaking corporate rescue in which Redx was returned from administration to the control of its directors and its shares were re-listed on AIM. Redx operated in the highly specialised pharmaceuticals sector and traded whilst in administration, raising a number of complex issues which were highly unusual in the context of an administration.  Eventually the joint administrators sold patents to a US pharmaceuticals company for US$40 million enabling the rescue. 
• the German administrator of a large group of companies in a complex global fraud with over €1billion of investors' funds.
• directors of a listed mining company in respect of a potential insolvency process.
• numerous lenders and receivers in the realisation of property assets.
• the administrators of over 30 related companies, owning over 30 caravan sites, in dealing with sales and issues as to ownership. 

I have the honour of being the chair of the R3 General Technical Committee, a member of the Policy group and a member of Council, as well as being a member of the Consulting Editorial Board for the LexisNexis Restructuring & Insolvency PSL product.

I am also the co-author of Insolvency Litigation (with Andrew Keay, Joseph Curl KC and Louis Doyle KC) published by Elgar in 2025.